E D I T O R ' S Q U E S T I O N
GEORGIE KOVACS
FOUNDER AND CEO , FEMPOWER HEALTH
The FemTech sector represents a significant leap forward in addressing the nuanced health challenges women face throughout their lives . While FemTech has made considerable inroads in areas like maternal health services and menstrual health products , significant opportunities still exist across various life stages and conditions , highlighting the vast untapped potential within the sector . However , the journey from innovation to widespread adoption is intricate , influenced by several pivotal challenges : effective go-to-market ( GTM ) strategies , the crucial role of specialised expertise on boards and advisory teams , and the overarching need to fill research gaps , particularly in areas like menopause which have historically been overlooked .
Navigating GTM complexities
A nuanced GTM strategy is essential for FemTech ’ s success , given the healthcare industry ’ s complex ecosystem . The sector ’ s cautious evolution , especially in sensitive areas like sexual health , underscores the need for strategies that build trust among healthcare providers and patients . Educating the market and advocating for underrepresented health issues are key steps toward overcoming historical biases and adoption barriers .
Mandate for expert leadership
FemTech ’ s potential is maximised when guided by boards possessing a blend of medical , technological , and market acumen . Specialised knowledge is paramount , particularly for complex conditions like endometriosis , where even top experts disagree on the cause and the role of existing , albeit not ideal , treatments ( e . g , get surgery or take a prescription drug that induces menopause . Leaders with deep expertise can navigate FemTech products through regulatory landscapes , market hesitancies and towards meaningful health outcomes .
Bridging research gaps
With President Biden ’ s US $ 12 billion investment in women ’ s health research , the spotlight on FemTech ’ s role in bridging research gaps has intensified . FemTech can contribute critical data through wearables , digital platforms , and direct patient feedback , driving advancements in historically underfunded areas of women ’ s health , such as menopause management post- WHI study concerns .
Expanding Horizons
FemTech ’ s evolution demonstrates a commitment to expanding solutions across life stages , from reproductive health to managing menopause symptoms . Companies like Maven Clinic illustrate this progression , initially focusing on maternal health before broadening their services to fertility and menopause .
Conclusion
The FemTech industry is at a pivotal juncture , with the power to transform women ’ s health through technology-driven solutions . By tackling GTM challenges , ensuring leadership with targeted expertise , and leveraging innovation to address research deficiencies , FemTech is paving the way for a future where comprehensive , stage-of-life healthcare solutions for women are not just envisioned but realised .
26 www . intelligenthealth . tech